Navigation Links
ReBuilder Medical Technologies, Inc. Announces Unique Arthritic Pain Accessory
Date:9/2/2009

CHARLES TOWN, W.Va., Sept. 2 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has released a new way to deliver the impulses of the ReBuilder for pain.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)

Physicians all over the U.S. are now using the ReBuilder as their first choice for the treatment of leg pain. Pain can be caused by many things, including Arthritis. Many of them are not registered with Medicare so that they can provide the ReBuilder to their patients with little or no out of pocket cost to the patient.

"While the ReBuilder has a 20 year proven track record for the treatment of chronic hand pain from neuropathy," said David Phillips, Ph.D. CEO., "some patients have used it successfully to treat their pain that originated from arthritis."

Additionally, Dr. Phillips reports: "This new way to administer the ReBuilder's signals is with a special conductive glove that replaces the common electrodes that have been used in the past."

Finally, Dr. Phillips told reporters today: "Now a patient with pain from arthritis can put on these form fitting gloves, turn on his ReBuilder, read his morning paper, and at the end of the 10 minute session he can feel the relief and can go about his normal activities symptom free. Now that Medicare covers the ReBuilder for pain, we expect another jump in sales."

Inquiries can be made at www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc.s Dr. Phillips to Speak to Ohio Investment Group
2. ReBuilder Medical Technologies, Inc. Announces Negotiations with National Medicare Provider
3. ReBuilder Medical Technologies, Inc. Announces Second Quarter 2009 Profits up 100%
4. ReBuilder Medical Technologies, Inc. Announces New York Marketing Agreement
5. ReBuilder Medical Technologies, Inc. Announces First Quarter 2009 is Profitable
6. ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech
7. ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09
8. ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion
9. ReBuilder Medical Technologies, Inc. Appears Recession Proof
10. ReBuilder Medical Technologies, Inc. Says No to OTC - Rather Wait for NASDAQ
11. ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - NASDAQ, here we come!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company ... NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic ... organizations that have excellent programs for the delivery and improvement of disease management ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... solution that enables organizations to easily reprint customer invoices, bills, statements and other ... all of the steps needed to retrieve and print the documents and batch ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... El Segundo, CA (PRWEB) , ... March 23, ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. ... primary source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 — ... the new EU MDR language change the way manufacturers approach CERs? , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... COPENHAGEN, Denmark , March 23, 2017 ... utilizes its innovative TransCon technology to address significant unmet ... company will host a conference call and webcast on ... of the Endocrine Society in Orlando, Florida ... rare disease pipeline candidates (TransCon Growth Hormone, TransCon PTH ...
(Date:3/23/2017)... 23, 2017 Prima BioMed has ... trial of IMP321 in combination with Keytruda, with one ... cohort experiencing a complete response. Recruitment in the second ... to be fully recruited by Q317. Preliminary efficacy data ... cancer study are expected mid-year (recruitment in the 226-patient ...
(Date:3/23/2017)... 2017 Piramal Pharma Solutions ... el nombramiento de Stuart E. Needleman ... servicios integrados completa para su base de clientes ... en el crecimiento y ejecución de las ofertas ... impulsar todas las actividades de desarrollo empresarial global ...
Breaking Medicine Technology: